WMSA
CADX

Weiss Multi-Strategy Advisers’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-90,000
Closed -$815K – 1266
2013
Q4 		$815K Buy
+90,000
New +$650K 0.02% 483

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CADX Position: Q1 2014 in Review

Weiss Multi-Strategy Advisers sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 90,000 shares — an estimated $815K sold.

Weiss Multi-Strategy Advisers first reported a position in CADX in Q4 2013 and held it in 1 quarter. The position peaked at $815K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Weiss Multi-Strategy Advisers reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 90,000 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $815K.
  • Weiss Multi-Strategy Advisers first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q4 2013 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $815K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2014, filed 15 May 2014.